Vascular risk factors in patients with Parkinson’s disease.Motor and cognitive aspects
Închide
Articolul precedent
Articolul urmator
311 3
Ultima descărcare din IBN:
2023-04-01 17:14
Căutarea după subiecte
similare conform CZU
616.858:616.1-06-036.1-07 (1)
Neurologie. Neuropatologie. Sistem nervos (963)
Patologia sistemului circulator, a vaselor sanguine. Tulburări cardiovasculare (975)
SM ISO690:2012
ROTARU, Lilia. Vascular risk factors in patients with Parkinson’s disease.Motor and cognitive aspects. In: 7th Congress of the Society of Neurologists Issue of the Republic of Moldova, Ed. 7, 16-18 septembrie 2021, Chişinău. Chişinău: Revista Curier Medical, 2021, Vol.64, p. 45. ISSN 2537-6381 (Online).
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
7th Congress of the Society of Neurologists Issue of the Republic of Moldova
Vol.64, 2021
Congresul "7th Congress of the Society of Neurologists Issue of the Republic of Moldova"
7, Chişinău, Moldova, 16-18 septembrie 2021

Vascular risk factors in patients with Parkinson’s disease.Motor and cognitive aspects

CZU: 616.858:616.1-06-036.1-07

Pag. 45-45

Rotaru Lilia
 
Diomid Gherman Institute of Neurology and Neurosurgery
 
Proiecte:
 
Disponibil în IBN: 28 septembrie 2021


Rezumat

Background: Vascular risk factors (VRFs) are common in Parkinson’s disease (PD) patients. Studies suggest the association of VRFs with motor severity and cognitive decline in PD. Material and methods: In 111 consecutive PD patients (mean age 64.87 ± 7.69 y.o.; disease duration 50.21 ± 38.61 mo.; 48 women (43.2%), 63 men (56.8%)) VRFs were assessed by QRISK3scale. Results: VRFs were present in 106 (95.5%) patients: HBP (High Blood Pressure) – 74 pts. (66.7%), dyslipidemia – 36 pts. (32.4%), DM (Diabetes Mellitus) – 20 pts. (18.0%), previous stroke – 14 pts. (12.6%), atrial fibrillation – 12 pts. (10.8%), smoking – 32 pts. (28.8%). Mean VRFs number per patient was 2.62 ± 1.39. PD onset age (60.44 ± 8.11 vs 60.80 ± 12.79) and disease duration (50.54 ± 38.74 vs 43.20 ± 39.44) were similar in groups. PD+VRFs patients had higher UPDRSon (36.11 ± 12.19 vs 20.00 ± 6.98, p = 0.011) and akinesia-rigidity scores (0.75 ± 0.61 vs 0.38 ± 0.13, p = 0.001). PDQ39(Parkinson’s Disease Questionnaire) (54.41 ± 27.67 vs 41.25 ± 20.16, p > 0.05) were higher, and MoCA (Montreal Cognitive Assessment) scores (21.64 ± 4.32 vs 22.60 ± 3.29) lower. Significant differences were found for MoCA naming (2.79 ± 0.41 vs 3.00 ± 0.00, p = 0.001), MoCA abstracting (1.46 ± 0.67 vs 2.0 ± 0.01, p = 0.001) and MoCA orientation (5.58 ± 0.99 vs 6.00 ± 0.01, p = 0.004) subscores. Conclusions: The frequency of vascular risk factors was high in our PD patients, the most common being HBP. Their presence was associated with motor severity and changes in specific cognitive subscores.

Cuvinte-cheie
Parkinson’s disease, vascular risk factors, MoCA test